Influence of plasma total antioxidant ability on lipid and protein oxidation products in plasma and erythrocyte ghost obtained from developing and adult rats pretreated with two vitamin K formulations.
Ferric reducing ability of plasma (FRAP), as an index of total antioxidant capacity of plasma was found to be enhanced significantly (p < 0.05) in suckling rats pretreated either with vitamin K1 (28, 56 or 84 mg/kg/3 days) or menadione (vitamin K3) at a dose of 15 mg/kg b.w./3 days. The effect of vitamin K1 on FRAP was dose-dependent and it was inversely related to the formation of lipid peroxidation products in plasma as judged by thiobarbituric acid reacting substances (TBARS). Lack of influence of the drugs on FRAP in adults was corroborated with elevation in the levels of plasma TBARS. Possible role of FRAP on the rate of lipid peroxidation and protein oxidation (protein carbonyls) on erythrocyte membrane was also investigated following isolation of erythrocyte ghost from control and treated rats. Vitamin K1 as well as menadione failed to change the levels of protein carbonyls in erythrocyte ghost obtained from both the age groups. Analysis of major erythrocyte membrane proteins, using SDS-polyacrylamide gel electrophoresis (SDS-PAGE) substantiated these results. In spite of higher antioxidant capacity of plasma and erythrocytes obtained from young rats, the rate of lipid peroxidation in erythrocyte ghost preparation was also high in this age group (p < 0.05). These results suggest that the drug-related induction in FRAP occurs only in immature animals as a part of protective mechanism against lipid peroxidation products generated in plasma.
Hadi
Ansari Hadipour
AH
Department of Biochemistry, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, I. R. Iran.
Abdolamir
Allameh
A
Mahtab
Hajhaidari
H
Abolfazl
Dadkhah
D
Yusef
Rasmi
R
D000284:Administration, Oral; D000375:Aging / Q000502:physiology*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D004910:Erythrocyte Membrane / Q000187:drug effects*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D010084:Oxidation-Reduction; D011506:Proteins / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D013997:Time Factors; D010837:Vitamin K 1 / Q000008:administration & dosage / Q000494:pharmacology*; D024483:Vitamin K 3 / Q000008:administration & dosage / Q000494:pharmacology*
D000975:Antioxidants; D011506:Proteins; D017392:Thiobarbituric Acid Reactive Substances; D024483:Vitamin K 3; D010837:Vitamin K 1